News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News Global Burden of HIV-Related CVD Has Tripled Over Two Decades Lucy Hicks July 13, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News ‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes Yael L. Maxwell June 29, 2018
News Daily News NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests Todd Neale June 21, 2018
News Daily News Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF Michael O'Riordan June 12, 2018
News Daily News Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations Todd Neale June 04, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Daily News Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests L.A. McKeown May 23, 2018
News Daily News FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests Todd Neale April 11, 2018
News Daily News Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study Shelley Wood February 01, 2018
News Daily News Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis Michael O'Riordan May 31, 2017
News Daily News FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words Shelley Wood January 13, 2017
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Fostering and Maintaining Cardiovascular Health in Children Key to a Healthier Population, Says AHA Michael H. Wilson August 11, 2016
News Daily News The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response L.A. McKeown July 28, 2016
News Daily News Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology Yael L. Maxwell June 24, 2016
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015